Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Traws Pharma (TRAW) Invested Capital (2016 - 2025)

Traws Pharma's Invested Capital history spans 14 years, with the latest figure at -$629000.0 for Q4 2025.

  • Quarterly results put Invested Capital at -$629000.0 for Q4 2025, up 98.01% from a year ago — trailing twelve months through Dec 2025 was -$629000.0 (up 98.01% YoY), and the annual figure for FY2025 was -$629000.0, up 98.01%.
  • Invested Capital for Q4 2025 was -$629000.0 at Traws Pharma, down from $4.5 million in the prior quarter.
  • In the past five years, Invested Capital ranged from a high of $49.7 million in Q3 2021 to a low of -$105.5 million in Q2 2024.
  • The 5-year median for Invested Capital is $16.7 million (2023), against an average of $13.0 million.
  • The sharpest move saw Invested Capital surged 646.88% in 2021, then plummeted 658.37% in 2024.
  • Year by year, Invested Capital stood at $46.1 million in 2021, then crashed by 38.62% to $28.3 million in 2022, then crashed by 62.3% to $10.7 million in 2023, then plummeted by 396.38% to -$31.6 million in 2024, then skyrocketed by 98.01% to -$629000.0 in 2025.
  • According to Business Quant data, Invested Capital over the past three periods came in at -$629000.0, $4.5 million, and $8.3 million for Q4 2025, Q3 2025, and Q2 2025 respectively.